Posted by Michael Wonder on 26 Jul 2017
A bid for HHS to override patents on pricey drugs is shot down
25 July 2017 - File this under “Nice try, but …
An Ohio congresswoman unsuccessfully attempted to make it possible for the U.S. Department of Health and Human Services to conduct an end run around companies that price drugs — developed with taxpayer dollars — higher than what is charged in seven other high-income countries.
